Michael Cooper Pearce's Net Worth

$1.1 Million

Estimate Recalculated Jul 23, 2024 03:03PM EST

Who is Michael Cooper Pearce?

Michael Cooper Pearce has an estimated net worth of $1.1 Million. This is based on reported shares across multiple companies, which include ENZON PHARMACEUTICALS, INC., SPATIALIZER AUDIO LABORATORIES INC, PERNIX THERAPEUTICS HOLDINGS, INC., and Myrexis, Inc..

SEC CIK

Michael Cooper Pearce's CIK is 0001413616

Past Insider Trading and Trends

2012 was Michael Cooper Pearce's most active year for acquiring shares with 16 total transactions. Michael Cooper Pearce's most active month to acquire stocks was the month of October. 2012 was Michael Cooper Pearce's most active year for disposing of shares, totalling 27 transactions. Michael Cooper Pearce's most active month to dispose stocks was the month of October. 2009 saw Michael Cooper Pearce paying a total of $223,668.10 for 120,001 shares, this is the most they've acquired in one year. In 2012 Michael Cooper Pearce cashed out on 327,386 shares for a total of $1,278,138.38, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ENZON PHARMACEUTICALS, INC. (ENZN) Snapshot price: $0.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-4.62%
-77.10K
$0.19
-$14,337.64
1.59M
Aug 24 - Aug 25
Form 4
+31.76%
506.29K
$0.20
$101,258.40
2.1M
Aug 5
Form 3
—
0
—
—
0
No matching records found

SPATIALIZER AUDIO LABORATORIES INC (ENVB) Snapshot price: $0.8

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

PERNIX THERAPEUTICS HOLDINGS, INC. No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+681.81%
250K
—
—
286.67K
May 10
Form 4
—
0
$5.60
-$27,840.40
36.67K
Scheduled
Nov 27 - Nov 28
Form 4
—
0
$5.72
-$105,556.30
36.67K
Scheduled
Nov 23 - Nov 26
Form 4
—
0
$5.73
-$63,221.50
36.67K
Scheduled
Nov 20 - Nov 21
Form 4/A
—
0
—
—
0
Scheduled
Oct 5 - Oct 9
Form 4/A
—
0
—
—
0
Scheduled
Oct 3 - Oct 4
Form 4
—
0
$5.74
-$138,327.88
36.67K
Scheduled
Nov 16 - Nov 19
Form 4
—
0
$6.10
-$4,894.40
36.67K
Scheduled
Oct 5 - Oct 9
Form 4
—
0
$6.07
-$105,105.80
120.47K
Scheduled
Oct 3 - Oct 4
Form 4
+37.50%
10K
—
—
36.67K
Mar 22
Form 4
—
0
$6.15
-$197,347.50
26.67K
Scheduled
Jan 24
Form 4
—
0
$5.32
-$91,602.00
26.67K
Scheduled
Sep 9 - Sep 12
Form 4
-3.38%
-933.00
$5.24
-$19,720.60
26.67K
Scheduled
Sep 7 - Sep 8
Form 4
-14.29%
-4.60K
$7.88
-$36,236.48
27.6K
Scheduled
Sep 2 - Sep 6
Form 4
-3.01%
-1.00K
$8.68
-$8,680.00
32.2K
Scheduled
Aug 31 - Sep 1
Form 4
-5.14%
-1.80K
$8.62
-$15,520.00
33.2K
Scheduled
Aug 29 - Aug 30
Form 4
+40.00%
10K
—
—
35K
Mar 11
Form 4
∞
25K
—
—
25K
Mar 10
Form 4
—
0
—
—
0
Dec 30
Form 4
—
0
—
—
0
Oct 25
Form 3
—
0
—
—
0
No matching records found

Myrexis, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Journey Medical Corp (DERM) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
30K
—
—
30K
Jul 19
Form 3
—
0
—
—
0
No matching records found